Prof Schattenberg, Germany, reviews how NASH impacts quality of life. He presents the mechanisms underlying metabolic comorbidities in NASH and discusses the relevant NASH phenotypes. A presentation of the tools that can be used to review health-related quality of life (HQRL) is particularly relevant for clinicians.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In

six − 1 =